Leila B. Cohen
Ramos Mejia, B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
From Polypharmacy to Plasticity: The Case for Neuromodulation in Palliative Care.
Journal: Journal of palliative medicine
Published: December 30, 2025
A mixed methods process evaluation of a collaborative outpatient palliative care clinic for patients with end-stage liver disease.
Journal: BMC palliative care
Published: September 23, 2025
Progression independent of relapse activity (PIRA) in the Era of high-efficacy treatments.
Journal: Multiple sclerosis and related disorders
Published: June 10, 2025
Access, satisfaction, adherence and safety to subcutaneous natalizumab compared to intravenous natalizumab in multiple sclerosis in a real-life cohort: first report from Latin America.
Journal: Therapeutic advances in neurological disorders
Published: April 01, 2025
Application of the international criteria for optic neuritis in the Acute Optic Neuritis Network.
Journal: Annals of clinical and translational neurology
Published: April 12, 2024
Long-term bereavement outcomes in family members of those who died in acute care hospitals before and during the first wave of COVID-19: A cohort study.
Journal: Palliative medicine
Published: January 16, 2024
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry.
Journal: Journal of the neurological sciences
Published: October 22, 2023
Comorbidities, symptoms and end-of-life medication use in hospitalised decedents before and during the COVID-19 pandemic: a retrospective regional cohort study in Ottawa, Canada.
Journal: BMJ open
Published: September 05, 2023
Clinical outcomes and prognostic factors in patients with optic neuritis related to NMOSD and MOGAD in distinct ethnic groups from Latin America.
Journal: Multiple sclerosis and related disorders
Published: October 14, 2022
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: September 27, 2022
Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina.
Journal: Multiple sclerosis and related disorders
Published: July 27, 2022
Last Updated: 09/26/2026